Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.

Vivoli M, Caulfield TR, Martínez-Mayorga K, Johnson AT, Jiao GS, Lindberg I.

Mol Pharmacol. 2012 Mar;81(3):440-54. doi: 10.1124/mol.111.077040. Epub 2011 Dec 14.

2.

Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations.

Brakch N, Rist B, Beck-Sickinger AG, Goenaga J, Wittek R, Bürger E, Brunner HR, Grouzmann E.

Biochemistry. 1997 Dec 23;36(51):16309-20.

PMID:
9405066
4.

Developmental expression of the prohormone convertases PC1 and PC2 in mouse pancreatic islets.

Marcinkiewicz M, Ramla D, Seidah NG, Chrétien M.

Endocrinology. 1994 Oct;135(4):1651-60.

PMID:
7925129
5.

Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor.

Ugleholdt R, Poulsen ML, Holst PJ, Irminger JC, Orskov C, Pedersen J, Rosenkilde MM, Zhu X, Steiner DF, Holst JJ.

J Biol Chem. 2006 Apr 21;281(16):11050-7. Epub 2006 Feb 13.

6.

Identification of inhibitors of prohormone convertases 1 and 2 using a peptide combinatorial library.

Apletalina E, Appel J, Lamango NS, Houghten RA, Lindberg I.

J Biol Chem. 1998 Oct 9;273(41):26589-95.

7.

Identification of a small molecule that selectively inhibits mouse PC2 over mouse PC1/3: a computational and experimental study.

Yongye AB, Vivoli M, Lindberg I, Appel JR, Houghten RA, Martinez-Mayorga K.

PLoS One. 2013;8(2):e56957. doi: 10.1371/journal.pone.0056957. Epub 2013 Feb 22.

9.

Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.

Dhanvantari S, Brubaker PL.

Endocrinology. 1998 Apr;139(4):1630-7.

PMID:
9528943
10.

Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2.

Damholt AB, Buchan AM, Holst JJ, Kofod H.

Endocrinology. 1999 Oct;140(10):4800-8.

PMID:
10499540
11.

Prohormone convertases (PC1/3 and PC2) in rat and human pancreas and islet cell tumors: subcellular immunohistochemical analysis.

Itoh Y, Tanaka S, Takekoshi S, Itoh J, Osamura RY.

Pathol Int. 1996 Oct;46(10):726-37.

PMID:
8916141
12.

Immunocytochemical localization of prohormone convertases PC1/PC3 and PC2 in rat pancreatic islets.

Tanaka S, Kurabuchi S, Mochida H, Kato T, Takahashi S, Watanabe T, Nakayama K.

Arch Histol Cytol. 1996 Aug;59(3):261-71.

PMID:
8874758
14.

The role of prohormone convertases PC1 (PC3) and PC2 in the cell-specific processing of proglucagon.

Mineo I, Matsumura T, Shingu R, Namba M, Kuwajima M, Matsuzawa Y.

Biochem Biophys Res Commun. 1995 Feb 15;207(2):646-51.

PMID:
7864855
15.

Processing of mouse proglucagon by recombinant prohormone convertase 1 and immunopurified prohormone convertase 2 in vitro.

Rothenberg ME, Eilertson CD, Klein K, Zhou Y, Lindberg I, McDonald JK, Mackin RB, Noe BD.

J Biol Chem. 1995 Apr 28;270(17):10136-46.

16.

[Structure and properties of proprotein convertase inhibitors].

Kibirev VK, Osadchuk TV.

Ukr Biokhim Zh (1999). 2012 Mar-Apr;84(2):5-29. Review. Russian.

PMID:
22642118
17.
18.
19.

Synthetic small-molecule prohormone convertase 2 inhibitors.

Kowalska D, Liu J, Appel JR, Ozawa A, Nefzi A, Mackin RB, Houghten RA, Lindberg I.

Mol Pharmacol. 2009 Mar;75(3):617-25. doi: 10.1124/mol.108.051334. Epub 2008 Dec 12.

20.

Biological processing of the cocaine and amphetamine-regulated transcript precursors by prohormone convertases, PC2 and PC1/3.

Dey A, Xhu X, Carroll R, Turck CW, Stein J, Steiner DF.

J Biol Chem. 2003 Apr 25;278(17):15007-14. Epub 2003 Feb 12.

Supplemental Content

Support Center